Zobrazeno 1 - 10
of 13
pro vyhledávání: '"G J, Schapel"'
Publikováno v:
Clinical and experimental neurology. 29
Our experience of using video-audio/EEG monitoring in the diagnosis and management of epilepsy at The Queen Elizabeth Hospital Comprehensive Epilepsy Service from March 1987 to December 1990 is described. We performed 75 long term monitoring studies
Publikováno v:
Therapeutic Drug Monitoring. 19:565
Publikováno v:
Medical Journal of Australia. 2:119-122
Publikováno v:
Australian and New Zealand Journal of Medicine. 5:202-210
Summary: A study of serum and myocardial digoxin concentrations in man during cardiac arrest. In 22 digitalized (of a total of 39) patients studied at random by radioimmunoassay during cardiac arrest, the mean serum digoxin concentration was 2·6 (±
Therapeutic Serum Digoxin Concentration: Relation to Age, Weight, Sex, and Serum Creatinine Levels‡‡
Publikováno v:
Australian and New Zealand Journal of Medicine. 3:606-613
Summary: Serum digoxin concentration was determined by radioimmuno-assay in a group of 41 hospitalized adult patients (22 males and 19 females), selected prospectively for constant effective dosage with digoxin for at least three weeks, without clini
Publikováno v:
Medical Journal of Australia. 1:142-144
Autor:
G. J. Schapel, Neaverson Ma
Publikováno v:
Medical Journal of Australia. 2:667-669
Publikováno v:
The Medical journal of Australia. 2(4)
Displacement of phenytoin from plasma proteins by valproate causes a reduction in total serum phenytoin levels. However, no adjustment of phenytoin dosage is warranted, unless clinically indicated, since the free phenytoin levels remain unchanged.
Autor:
G J, Schapel, K D, Edwards
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 194(1)
Nephrotic mixed hyperlipidemia may be associated with accelerated coronary artery disease. To investigate the response of experimental nephrotic hyperlipidemia to therapy, a 2(4) factorial study of sodium clofibrate and beta-benzalbutyrate, halofenat
Publikováno v:
Progress in biochemical pharmacology. 9